Related Experiment Video
Updated: Jun 5, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Phosphorylation of the anaphase-promoting complex/Cdc27 is involved in TGF-beta signaling
Liyong Zhang1, Takeo Fujita, George Wu
1Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
Loss of TGF-β-induced growth inhibition is a hallmark of many human tumors. Previous studies implied that activation of the anaphase-promoting complex (APC/cyclosome) is involved in the TGF-β signaling pathway, which facilitates the destruction of SnoN, a transcriptional co-suppressor, which leads in turn to the transactivation of TGF-β-responsive genes for cell cycle arrest. The function of APC was demonstrated in TGF-β signal transduction, but the mechanism by which it is activated in response to TGF-β signaling remains unclear. We report here that phosphorylation of Cdc27, a core subunit of APC, in response to TGF-β signaling can facilitate the activation of APC. We have demonstrated that casein kinase II (CKII) is involved in the phosphorylation of Cdc27 in response to TGF-β signaling. Depletion of CKII by shRNA abolishes the TGF-β-induced phosphorylation of Cdc27 and subsequent degradation of SnoN. Disruptive mutation of Cdc27 (S154A) attenuates TGF-β-induced SnoN degradation. In addition, expression of a phosphorylation-resistant Cdc27 mutant significantly attenuates TGF-β-induced growth inhibition. Together, the results suggest that phosphorylation of Cdc27 by CKII is involved in TGF-β-induced activation of APC.
Insights
Transforming growth factor-beta (TGF-β) signaling loss in tumors is linked to cancer. This study reveals casein kinase II (CKII) phosphorylates Cdc27, activating the anaphase-promoting complex (APC) for cell cycle arrest.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Loss of TGF-β-induced growth inhibition is a hallmark of human tumors.
- The anaphase-promoting complex (APC/cyclosome) is implicated in TGF-β signaling, promoting SnoN degradation and cell cycle arrest.
- The precise mechanism of APC activation by TGF-β remains unclear.
Purpose of the Study:
- To elucidate the mechanism of APC activation in response to TGF-β signaling.
- To investigate the role of Cdc27 phosphorylation in TGF-β-induced APC activation.
- To identify the kinase responsible for Cdc27 phosphorylation in this pathway.
Main Methods:
- Investigated TGF-β signaling effects on Cdc27 phosphorylation.
- Utilized shRNA to deplete casein kinase II (CKII).
- Employed site-directed mutagenesis of Cdc27 (S154A) and phosphorylation-resistant mutants.
Main Results:
- TGF-β signaling induces Cdc27 phosphorylation, facilitating APC activation.
- CKII is identified as the kinase responsible for Cdc27 phosphorylation in response to TGF-β.
- CKII depletion abrogates TGF-β-induced Cdc27 phosphorylation and SnoN degradation.
- Cdc27 mutations impair TGF-β-induced SnoN degradation and growth inhibition.
Conclusions:
- Phosphorylation of Cdc27 by CKII is a key step in TGF-β-induced APC activation.
- This pathway is crucial for TGF-β-mediated growth inhibition and tumor suppression.
Related Concept Videos
TGF - β Signaling Pathway
Anaphase Promoting Complex
Anaphase Promoting Complex
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway

